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Abstract
Purpose This study was designed to assess retrospec-
tively short- and mid-term outcomes of the use of a suture-
mediated closure device to close the antegrade access in
patients undergoing percutaneous aspiration thrombectomy
with large catheters for acute leg ischemia.
Methods Between November 2005 and February 2010, a
suture-mediated active closure system (ProGlide 6F,
Abbott) was placed before arterial sheath (mean 9 F, range
6–12 F) introduction in 101 patients (74 men, 73 %, mean
age 70.1 ± 12.6 years standard deviation). Data regarding
mortality, complications, and factors contributing to vas-
cular complications at the access site was collected for
6 month after the intervention to detect device-related
problems. As a coincidence, 77 patients had follow-up
visits for a duplex ultrasound.
Results There were a total of 19 vascular complications
(19 %) at the puncture site, all of which were of hemor-
rhagic nature and none of which consisted of vessel
occlusion. Two major outcome complications (2 %)
occurred. A retroperitoneal hematoma and a serious ingui-
nal bleeding required additive treatment and did not result
in permanent sequelae. Nine cases involved death of which
eight were not attributable to the closure and one remained
unclear. Successful closure was achieved in 95 patients
(94 %); additional manual compression was sufficient in the
majority of the remaining patients. Numerous factors con-
tributing to vascular complications were encountered.
Conclusions With acceptable short- and mid-term out-
comes, the ‘‘preclose’’ technique can be a reliable option
for the closure of a large antegrade femoral access even for
patients at a high risk of vascular complications, such as
those undergoing aspiration thrombectomy.
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Introduction
Acute leg ischemia, a manifestation of peripheral arterial
disease, carries a high risk of amputation and mortality. For
the treatment and the prevention of its sequelae, emergent
percutaneous or surgical revascularization is used. For
acute leg ischemia, percutaneous techniques are sufficient
to resolve the occlusion in most of the cases and in par-
ticular elderly patients benefit from nonsurgical alterna-
tives [1–3].
Percutaneous aspiration thrombectomy (PAT) has been
a proven and effective technique since it was first described
by Sniderman in 1984 [1–3]. Adjunctive use of catheter-
directed local thrombolysis or mechanical clot fragmenta-
tion with angioplasty balloons may be adopted to facilitate
the aspiration therapy. The technique of PAT requires the
use of large access site end-hole catheters and a syringe to
aspirate clots from vessels. The main limitation of the
aspiration technique often involves the size and burden of
the clot. To facilitate the procedure, larger aspiration
catheters and consequently larger introduction sheaths,
which are inherently associated with more access site
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complications, are desirable [1–3]. To control bleeding
complications, a quick and reliable closure of the large
access site is mandatory. The ‘‘preclose’’ technique, an off-
label use of a suture-mediated vessel closure device (VCD;
ProGlide) described for percutaneous endovascular aortic
repair, may fulfill these specific needs of PAT [4].
The purpose of this study was to analyze retrospectively
the clinical outcomes of using a suture-mediated VCD for
antegrade closure of large access sites in a sample of
patients with acute limb-threatening ischemia undergoing
PAT.
Materials and Methods
Study Design
This study was conducted according to the standards of the
declaration of Helsinki. Due to the retrospective nature of
this study, the local ethical committee waived institutional
review board approval. All patients gave written consent
for the clinically indicated thrombectomy procedures. The
interventionists performing the procedures had more than
4 years of experience in this particular field.
A single-center registry was constructed to assess the
clinical outcomes of a suture-mediated closure system
(ProGlide 6F, Abbott Vascular, Redwood City, CA) in
patients undergoing PAT. The device was approved by the
FDA in 1997 for retrograde closure of arterial access sites
up to 8 F [5]. The ProGlide consists of a monofilament
suture deployed with an automated, pre-tied knot to close
the femoral artery by arterial wall approximation. We
adopted the known ‘‘preclose’’ modification of its standard
application for antegrade closure of the common and
proximal superficial femoral artery.
Intervention
After local anesthesia, the same 20 G needle was utilized
to perform the antegrade puncture of the common femoral
or proximal superficial femoral artery and the initial
angiogram of the common femoral artery bifurcation in a
30 oblique projection. Depending on the presence of
arteriosclerotic disease, the caliber of the artery, and the
extension of the arterial occlusion at the puncture site, a
second ‘‘higher’’ or more distal puncture was performed.
Attention was paid to these anatomical issues, because they
may interfere with the introduction of the ProGlide or
respectively, with the pull-back of its anchoring foot. Using
Seldinger’s technique a 0.018’’ guidewire (V-18 Control
Wire, Boston Scientific Corp., Natick, MA) was introduced
and advanced into the superficial femoral artery to
exchange the access needle for a 6- or 7-F vascular dilator.
Then, a single ‘‘preclosure’’ of the femoral access was
performed with a commercially available 6-F suture-med-
iated closure device (ProGlide, Abbott Vascular Inc.,
Redwood City, CA) according to the known technique [6].
The initial introducer size (6–12 F) was chosen based on
the diameter of the vessel accessed and the amount of
thrombus to be removed. At this stage a bolus of 5,000 IU.
of unfractionated heparin was given if the patients were not
already on a heparin drip or on therapeutic oral anticoag-
ulation. The clot aspiration was subsequently performed
with a 50 cc syringe (to obtain the vacuum) attached to a
straight aspiration catheter (6–9 F, Angiomed, subsidiary
of CR Bard Inc., Karlsruhe, GE) [7].
If the aspirated clot was repeatedly ‘‘lost’’ as it was
pulled through the sheath, the latter was upsized by at least
2 F. We preferred the 11 cm Avanti introducer (Cordis
Corp., Miami Lakes, FL) for this procedure, because it can
be clamped easily with a hemostat and because its cap at
the hub can be removed easily and reinstalled to facilitate
withdrawal of larger clots. If this simple maneuver failed,
the thromboembolus was additionally lysed by a course of
hand- or injector-driven catheter directed pulse-spray
thrombolysis (200,000 IU of urokinase, 5 F multi-slit
catheter/Uni*Fuse, AngioDynamics, Queensbury, NY),
followed by mechanical angioplasty balloon fragmentation.
Then, aspiration thrombectomy was resumed. Any under-
lying lesions were treated by balloon angioplasty with or
without stenting. In the few instances of acutely throm-
bosed popliteal aneurysms, stent-grafts were placed first
and flow restoration by aspiration thrombectomy was per-
formed thereafter. Finally, the introducer was removed and
puncture site hemostasis was achieved by tying the pre-
placed ProGlide suture. To keep the option of an addi-
tional ProGlide placement in case of persisting bleeding,
the ‘‘safety’’ guidewire was removed after tying the suture.
Activated clotting time measurements were not routinely
performed before the accesses were closed.
Inclusion Criteria and Patient Sample
A search of the interventional database of our department
revealed 145 interventions with the combined utilization of
an aspiration thrombectomy catheter and the aforemen-
tioned device from November 2005 to February 2010.
After exclusion of retrograde iliac thrombectomies, 119
antegrade interventions were left. To simplify statistical
analysis, only the first intervention per patient was counted,
resulting in a total of 101 patients. Separation into sub-
groups for the analysis of the factors contributing to vas-
cular complications at the access site led to 19 patients with
and 82 without complications. The patients were referred
for emergent percutaneous revascularization either directly
from smaller hospitals (n = 17, 17 %) or from the
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department of vascular surgery (n = 18, 18 %) or the angi-
ology clinic (n = 66, 65 %) of our center. The angiology
clinic conducted the postinterventional examination of all
patients according to a standardized clinical follow-up pro-
tocol. Within 24 h after the intervention, every patient had
follow-up consisting of a physical examination, determina-
tion of ankle-arm pressures, and pulse-volume recording.
Further examinations followed after 3 and 6 months for the
patients from the Department of Vascular Surgery and the
angiology clinic. In 77 patients (76 %), an additional duplex
ultrasound was performed by a vascular specialist. The
ultrasound follow-up is incomplete, because this examina-
tion was initially performed on demand and later routinely.
Data Collection
Based on a review of the pertinent literature, a screening
chart was created identifying complications and factors that
likely contribute to vascular complications. The patient
data were gathered from the picture archives and patient
information system of the hospital. Emphasis was placed
on angiograms and postinterventional documentation,
including the first follow-up. According to an internal
policy of the interventional team, the operator always took
floor notes regarding successful or unsuccessful closure
and consequences, such as additional external compression.
The scrutinized information was cross-checked with the
discharge notes. Special attention was drawn to the cause
of deaths and to factors that influenced each complication.
Vascular complications were weighted according to the
clinical outcome classification of the SIR [8]. Data in
Tables 1 and 2 were extracted from the screening chart.
Definitions
Early and late complications were defined separately as
occurring within 24 h after the intervention and at
6 months, respectively. The deployment of the device and
the closure of the antegrade puncture site were regarded as
successful when no additional compression and just a
single device were needed.
Everything from persistent mild oozing to serious blood
loss was categorized as bleeding. Hematomas were subdi-
vided according to their localization into inguinal and
retroperitoneal. Factors with a possible influence on com-
plications are listed in Table 2.
Statistical Analysis
All tests were calculated at a significance level of
a = 0.05, and confidence intervals were computed at a
confidence level of 95 %. Proportions were complemented
with a Wilson confidence interval ([9], including continuity
correction). Nominal variables were described as frequen-
cies and percentages, whereas the mean ± standard devi-
ation and ranges were provided for the continuous
variables. Tests between groups were performed with SPSS
19 for Windows (SPSS, Chicago, IL). Nominal variables
were compared using v2 or Fisher’s exact tests, depending
on the expected frequency in each cell. Continuous vari-
ables were compared using the t or Wilcoxon test,
depending on a visual check of normality of the underlying
measurements. A unifactorial ANOVA was applied when
appropriate.
Table 1 Fatalities
Age (year),
gender
Time after
intervention
Cause of death Background and details
1 85, female 1 day Heart failure Physicians of the intensive care unit suspected a cardiac reason; PAT was performed
because of an embolic arterial occlusion
2 65, male 4 days Multiorgan
dysfunction
Anastomotic bleeding of infected aortobiiliacal graft, postinterventional
contralateral iliac vessel occlusion, rhabdomyolysis
3 80, female 4 days Multiorgan
dysfunction
Sepsis in the setting of ischemic colitis, aortic graft of infra renal aneurysm;
retroperitoneal hematoma 2 days postintervention
4 75, male 9 days Multiorgan
dysfunction
Aortic bifurcated graft, aortoduodenal fistula
5 58, male 1 month Heart failure Terminal heart insufficiency, coronary and valvular heart disease, listed for
transplantation
6 93, female 2 months ‘‘Old age’’ Information obtained from relatives
7 88, male 5 months ‘‘Old age’’ Information from the nursing home
8 77, male 7 months Cancer Disseminated bladder cancer
9 62, male 1 year Not known At 6 month follow-up, no clinical abnormalities
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Results
Successful closure was achieved in 95 patients (94 %;
Wilson confidence interval: 87, 98). Device failure was
immediately detected clinically and solved in three patients
by placement of more than one device (ProGlide), in two
patients by external compression, and in the remaining
patient by crossover placement of a stent-graft. Table 2
summarizes the incidence of factors that likely contribute
to vascular complications in the whole study cohort.
Closure was always performed by one of four operators
with prior experience in retrograde and antegrade closures
Table 2 Patient characteristics, adjunctive treatments, and factors possibly associated with vascular complications
Type Patients p values
(n = 101)
Gender 74 (73 %) men p1 = 0.54
27 (27 %) women p2 = 1.00
Age (year) Mean 70.1 ± 12.6 p1 = 0.64
Range 18–93 p2 = 0.64
BMI (kg/m2) Mean 26.5 ± 4.9 p1 = 0.87
Range 19–40 p2 = 0.31
Artery/diameter
at the access site
21 (21 %) AFS p1 = 0.25
80 (79 %) AFC p2 = 0.49
Sclerosis 0 = 23 (23 %) 2 = 21 (21 %) p1 = 0.046
1 = 34 (33 %) 3 = 23 (23 %) p2 = 0.77
Ectasia/aneurysm 6 (6 %) p1 = 0.39
Scarring 1 (1 %) p2 = 0.16 (‘‘anatomical
variation’’)
Etiology/location
of occlusion
Thrombotic 70 (69 %); embolic 31 (31 %) p1 = 0.76
p2 = 0.69 (etiology)Femoral 23, popliteal 18, crural 10, femoropopliteal 15,
popliteo-crural 14, femoropopliteo-crural 21
Fluoroscopy time (min) Mean 29 ± 18.7 p1 = 0.95
Range 2–90 p2 = 0.2
Sheath dwell time (min) Mean 96.4 ± 52.9 p1 = 0.22
Range 13–293 p2 = 0.46
Duration of hospital
stay (days)
Mean 11.6 ± 17.6 p1 = 0.13
Range 0–115 p2 = 0.12
Maximum sheath size (F) Mean 9.3 ± 1.2 p1 = 0.55
Range 6–12 p2 = 0.16
Prior OAC (INR [ 1.4) 30 (30 %) p1 = 0.47
p2 = 0.5
Unfractionated heparin preinterventional bolus 61 (60 %); (2,500–12,500 IU) p1 = 0.07
i.v. infusion 58 (57 %); (10,000–30,000 IU per 24 h) p2 = 0.14
None 5 (5 %)
Anti-aggregation ASS ? clopidogrel 32 (32 %) clopidogrel 3 (3 %) p1 = 0.94
ASS 45 (44 %) none 21 (21 %) p2 = 0.71
‘‘On-table’’ urokinase 71 (70 %); (intrathrombic, 50,000–1,000,000 U) p1 = 0.7
p2 = 0.49
PTA (also utilized for
clot fragmentation)
66 (65 %) p1 = 0.51
p2 = 0.79
Stent or stent-graft
placement
39 (39 %) p1 = 0.44
p2 = 0.67
BMI body mass index, AFC common femoral artery, AFS superficial femoral artery, FT fluoroscopy time, SDT sheath dwell time, OAC oral
anticoagulation, ASS acetylsalicylic acid 100 mg, clopidogrel 75 mg, PTA percutaneous transluminal arterial angioplasty
0 no calcifications, I slight calcifications, II moderate calcifications, III severe calcifications, p1 p value of the adequate statistical test for
association of one factor and the group with and without complications, p2 p value of the adequate statistical test for association of one factor and
the subgroups of complications
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using the ProGlide. All patients underwent suction
thrombectomy because of acute or subacute ischemia of the
lower extremities. The targeted thrombus could be
removed in 83 (82 %) patients with a subsequent sufficient
crural run-off. The primary result was only partially suc-
cessful in 15 (15 %) patients, with failure in 3 (3 %)
patients. Dissection (n = 5, 5 %) or vessel perforation
(n = 2, 2 %) was rare and was remote from the access site.
In one patient, a femoral-crural bypass was directly
accessed and closed with the device four times (4 %)
during the course of the data collection period. However, as
stated above, just the first intervention was included in the
statistical analysis. Lower leg fasciotomy was performed in
14 (14 %) cases and amputation in 6 (6 %) cases; both
were necessary due to reperfusion syndrome and irrevers-
ible ischemia, respectively, and not caused by the VCD.
Salvage bypass surgery was not deemed appropriate for the
patients with failed limb revascularization.
Overall, 19 patients (19 %; Wilson confidence interval:
12, 28) had a composite of different vascular complications
at the puncture site. None required surgical repair.
In one very obese patient, the VCD failed and sub-
sequent serious bleeding had to be stopped by crossover
stent-grafting (Figs. 1, 2), because manual compression of
the superficial femoral artery was not considered an option
in this particular patient.
In another patient, a retroperitoneal hematoma was
confirmed by a CT scan 2 days after the intervention.
Blood transfusions had been administered to this patient.
The access site was below the inferior epigastric artery on
the same side as the hematoma. According to the operator’s
note, the access closure had been unremarkable. This
patient died 2 days later. Taking into account the autopsy
findings, sepsis related to the known ischemic colitis fol-
lowed by multiple-organ failure was assumed to be the
primary cause of death (Table 1).
For three minor bleedings or oozing, manual compression
was sufficient. Seven patients developed inguinal hemato-
mas. These complications were discovered clinically, and
hematomas were verified by ultrasound. None of these
patients with hematomas required any specific treatment.
Duplex ultrasound revealed one false aneurysm. At the
puncture site, the common femoral artery was ectatic and
showed mild calcification. A 10 F sheath had been used for
the PAT. Ultrasound-guided compression therapy was
successful.
No record of a device-related arteriovenous fistula,
infection requiring antibiotics, embolization, nerve injury,
or vascular stenosis leading to ischemia was found.
Taking into account only the 84 patients from the
angiology clinic and the Department of Vascular Surgery
with available post-discharge follow-up visits, no late
complications were found.
Among the nine (9 %) cases of death, five occurred within
the first month after the intervention. No relationship was
observed between death and intervention in the information
system (Table 1). However, in the patient with the retro-
peritoneal hematoma described above, a contribution by the
VCD to the death of the patient could not be excluded.
A box plot analysis of continuous factors from Table 2
showed trends toward more deployment complications
(Fig. 3). For BMI, fluoroscopy time and sheath dwell time
differences appeared only in the subgroup analysis for the
type of complication. Regarding hospitalization time and
sheath size, differences were already visible in the group
containing all complications. Nevertheless, none of the
different statistical tests was significant (p [ 0.05) for any
combination of the type of complication or for the overall
complication group with any of the factors.
Discussion
This retrospective study examined a suture-mediated VCD
for the closure of large arterial access sites after antegrade
femoral access in patients undergoing PAT. This setting
involves several comorbidities and factors that contribute
to access site complications.
Regarding short-term outcomes, the apparently high rate
of early complications (19 %) has to be cautioned. Similar
procedures have a broad range of hemostatic complication
rates for manual compression and VCD [10–13]. Depend-
ing on the definitions, the accuracy of follow-up protocols,
and diagnostic tools used, complication rates as high as
64 % have been reported [14]. The majority of our patients
had duplex-ultrasound in the 24 h follow-up, and for every
patient we had floor notes from the operator stating details
about the closure. Thus, we uncovered even small and
clinically non-relevant hematomas and bleedings. Severe
complications that required additional treatment and pro-
longed hospital stay occurred in only two patients (2 %).
The data most comparable to our setting are those from
Duda et al. [15], who used a similar suture-mediated VCD
(Perclose Techstar) in antegrade femoral accesses. Their
patients underwent femoropopliteal angioplasties of
essentially chronic ischemic limbs. Furthermore, that study
included fewer patients, and only a few underwent aspi-
ration thrombectomy, resulting in smaller introducer sheath
sizes. The overall early access complication rate in Duda’s
study was 12.5 % with major complications in 1 %.
Regarding the midterm outcomes, the literature reports
that infectious complications usually occur within 2 weeks
[16], whereas occlusive changes take place up to 6 months
after the intervention [17]. We observed our patients for
6 months after discharge, and neither ischemic nor late
infectious complications were reported. This finding is
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Fig. 1 A 54-year-old morbidly
obese male underwent
percutaneous treatment of an
acutely thrombosed popliteal
aneurysm with stent-graft
placement, ‘‘on-table’’
thrombolysis, and PAT. We
chose to access the superficial
femoral artery, because
antegrade puncture of the
common femoral artery would
have resulted in a steep
angulation of the device or
respectively the introducer
sheath. There was serious
bleeding at the puncture site
after suture-mediated closure.
The white arrows in (A) and
(B) point to the leakage around
the 11 F sheath. The sheath had
been re-advanced for
hemorrhage control over the
‘‘safety wire’’ after the knot of
the Perclose had been tied.
Using a crossover technique,
stent-graft insertion (Hemobahn
10 9 50 mm; Gore Associates,
Flagstaff, AZ) (C) and
expansion (D) were performed
to seal the hole. On the
completion angiogram (E), the
superficial femoral artery access
was sealed. Surgical treatment
was not considered because of
its high risk of groin infection in
this obese patient
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probably related to the device, which is collagen-free [5].
Thus, the inflammatory response is missing, and collagen
cannot be deposed intra-arterially. Additionally, in 2004 the
manufacturer improved the trimming mechanism and
changed the braided suture to a more inert monofilament
[6]. Hence, it was shown in the literature that infections are
less likely even though the suture represents a permanent
foreign material [18]. For the same reasons, vascular injury
with the device resulting in ischemic complication seems to
be unlikely [19]. However, cases have been occasionally
reported even after 2004 [20]. A device-specific risk is
assumed related to the intra-arterial foot of the device,
which may cause a dissection of the arterial wall. In our
experience, this is not a major concern. However, we made
sure that the vessel was not diseased and large enough at the
puncture site. Indeed, we did not observe any device-related
dissections even after proximal superficial femoral access.
Immediate hemostatic failures were uncommon, and
manual compression or a second device was sufficient to
achieve hemostasis except in the patient treated with a
crossover stent-graft. These results are comparable to
published data [6, 10, 15].
Fig. 2 Follow-up CTA performed at 80 days. The axial image
(A) depicts the scarring of the long puncture tract in the subcutaneous
fat tissue (white arrow) as well as the patent stent-graft within the
superficial femoral artery (black arrow). Volume rendered CTA (B),
clarifying the anatomy
Fig. 3 Box plots of an
exemplary risk factor on the
ordinate (BMI = body mass
index in kg/m2) and its
distribution within different
subgroups as described on the
abscissa. For patients with and
without any complications, the
box plots were similar. After
dividing the complications into
groups for the type of
complication, the subgroup with
the device problems showed a
higher median; higher and
wider IQR (interquartile range)
and higher minima and maxima
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The highly selected patient sample (i.e., one type of
device, only antegrade insertions, just patients undergoing
PAT) may explain why no statistical test could reach a
significant difference between the groups with and without
complications. Most of the patients had many of the factors
summarized in Table 2, regardless of their group affiliation.
Our hypothesis is supported by many studies that showed
the influence of coexisting factors included in Table 2 on
the rate of VCD-related access site complications [21].
Moreover, descriptive box plot analysis revealed trends
toward the anticipated direction. Further assessments in this
high-risk-group will unlikely supply useful data.
Important limitations of the study relate to its retrospec-
tive nature. For instance, in the only fatality, it is difficult to
retrospectively analyze to what extent the retroperitoneal
hematoma contributed to the death of the patient. The anti-
coagulation regimen was all but uniform. Immediately
before the intervention was started, one third of the patients
were receiving warfarin and two thirds of them were on a
therapeutic dose of intravenous heparin. Furthermore, 70 %
of the patients received nonstandardized amounts of uroki-
nase during the procedure. This spectrum of anticoagulation
management is essentially inherent to any revascularization
treatment of acute ischemic limbs. Nevertheless, a global
anticoagulation assessment (i.e., ACT) at the completion of
the intervention would have been useful.
Regarding the late complications, 17 outpatients without
a complete 6-month follow-up had to be excluded, which
lowered the credibility of our findings regarding midterm
outcomes.
Conclusions
This retrospective study showed that by integrating the
‘‘preclosure’’ technique into the time-tested PAT with large
catheters, acute lower limb ischemia can be treated suc-
cessfully at an acceptable rate of ponderable complications
at the access site. Additionally, no VCD-related infectious
or ischemic complications were discovered at midterm
follow-up.
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